ORGANOGENESIS HOLDINGS INC. Accrued Royalties, Current
ORGANOGENESIS HOLDINGS INC. (ORGO) had Accrued Royalties, Current of $1.70 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:AccruedRoyaltiesCurrent · last filed 2026-02-26
- 2025-12-31: Accrued Royalties, Current $1.70M.
- 2025-09-30: Accrued Royalties, Current $4.03M.
- 2025-06-30: Accrued Royalties, Current $5.58M.
- 2025-03-31: Accrued Royalties, Current $4.98M.
| Period end | Accrued Royalties, Current |
|---|---|
| 2025-12-31 | $1.70M 10-K · filed 2026-02-26 |
| 2025-09-30 | $4.03M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $5.58M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $4.98M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $7.38M 10-K · filed 2026-02-26 |
| 2024-09-30 | $7.72M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $8.92M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $6.58M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $3.08M 10-K · filed 2025-02-27 |
| 2023-09-30 | $2.86M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $3.21M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $3.04M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $3.32M 10-K · filed 2024-02-29 |
| 2022-09-30 | $3.54M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $3.70M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $3.19M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $3.46M 10-K · filed 2023-03-01 |
| 2021-09-30 | $3.34M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $2.72M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $2.85M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $2.97M 10-K · filed 2022-03-01 |
| 2019-12-31 | $2.87M 10-K · filed 2021-03-16 |
| 2018-12-31 | $2.46M 10-K · filed 2019-03-18 |
| 2017-12-31 | $3.61M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |